Haddadi A[au] - Search Results

Year	Number of Results
2004	1
2005	1
2006	2
2007	1
2008	6
2009	2
2010	5
2011	11
2012	4
2013	5
2014	6
2015	7
2016	1
2017	10
2018	3
2019	4
2020	5
2021	6

1

Uludağ H, Parent K, Aliabadi HM, Haddadi A. Uludağ H, et al. Among authors: haddadi a. Front Bioeng Biotechnol. 2020 Jul 30;8:916. doi: 10.3389/fbioe.2020.00916. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32850752 Free PMC article. Review.

2

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.

Rafiei P, Haddadi A. Rafiei P, et al. Among authors: haddadi a. Int J Nanomedicine. 2017 Jan 27;12:935-947. doi: 10.2147/IJN.S121881. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28184163 Free PMC article.

3

Combination of Innate Immune Modulators as Vaccine Adjuvants in Mice.

Haddadi A, Chaffey A, Ng SH, Yalamati D, Wilson HL. Haddadi A, et al. Vaccines (Basel). 2020 Oct 1;8(4):569. doi: 10.3390/vaccines8040569. Vaccines (Basel). 2020. PMID: 33019524 Free PMC article.

4

Implementation of a novel self-induced promoter for the expression of pharmaceutical peptides in Escherichia coli: YY(3-36) peptide.

Momen AH, Harzandi N, Haddadi A, Bambai B. Momen AH, et al. Among authors: haddadi a. Horm Mol Biol Clin Investig. 2019 May 28;41(1):/j/hmbci.2020.41.issue-1/hmbci-2018-0056/hmbci-2018-0056.xml. doi: 10.1515/hmbci-2018-0056. Horm Mol Biol Clin Investig. 2019. PMID: 31136297

5

Metagenomic investigation of bacteria associated with dental lesions: a cross-sectional study.

Kazemtabrizi A, Haddadi A, Shavandi M, Harzandi N. Kazemtabrizi A, et al. Among authors: haddadi a. Med Oral Patol Oral Cir Bucal. 2020 Mar 1;25(2):e240-e251. doi: 10.4317/medoral.23326. Med Oral Patol Oral Cir Bucal. 2020. PMID: 32040467 Free PMC article.

6

Potentiating Antigen Specific Immune Response by Targeted Delivery of the PLGA-Based Model Cancer Vaccine.

Jahan ST, Sadat SMA, Yarahmadi M, Haddadi A. Jahan ST, et al. Among authors: haddadi a. Mol Pharm. 2019 Feb 4;16(2):498-509. doi: 10.1021/acs.molpharmaceut.8b00700. Epub 2019 Jan 23. Mol Pharm. 2019. PMID: 30477303

7

Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.

Rafiei P, Haddadi A. Rafiei P, et al. Among authors: haddadi a. Pharm Nanotechnol. 2017;5(1):3-23. doi: 10.2174/2211738505666161230110108. Pharm Nanotechnol. 2017. PMID: 28948907 Review.

8

Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation.

Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Mirzaei S, et al. Among authors: haddadi a. Biomed Pharmacother. 2021 Jan;133:111077. doi: 10.1016/j.biopha.2020.111077. Epub 2020 Dec 4. Biomed Pharmacother. 2021. PMID: 33378975 Free article. Review.

9

Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.

Jahan ST, Sadat SMA, Walliser M, Haddadi A. Jahan ST, et al. Among authors: haddadi a. J Drug Deliv. 2017;2017:9090325. doi: 10.1155/2017/9090325. Epub 2017 Dec 31. J Drug Deliv. 2017. PMID: 29464123 Free PMC article. Review.

10

Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation.

Yang R, Lemaître V, Huang C, Haddadi A, McNaughton R, Espinosa HD. Yang R, et al. Among authors: haddadi a. Small. 2018 Mar;14(12):e1702495. doi: 10.1002/smll.201702495. Epub 2018 Feb 12. Small. 2018. PMID: 29430869 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results